CORZ NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Core Scientific, Inc. Common Stock · Technology · Software - Infrastructure

Open interactive chart View report data Download investor PDF
Latest close 22.75 USD
8.6% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 11.3% above the Trend Line and sits at 56.8% of its 52-week range. The latest completed week returned 8.6%, after a -16.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 52/100 conviction, while the latest news-sentiment score is 47/100. Near-term considerations: volume confirmation is below normal; earnings are due in 15d.

Setup score 47 out of 100
Latest Close 22.75 USD 24 Jul 2026
1W Return 8.6% latest completed week
4W Return -16.4% short-term follow-through
12W Return 11.8% quarterly tape
Trend Breadth 82.7% 43 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 12-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 2 reversal markers appear in the recent smart-money tape.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 8.6% Latest completed week; four-week move -16.4%. Indicator stack 87/31 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 52/100 conviction; expected move 9.9%. News sentiment 47/100 51 relevant articles in the latest sentiment read. Event risk 15d Next report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 11.3% above the Trend Line and sits at 56.8% of its 52-week range. The latest completed week returned 8.6%, after a -16.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8312-week average 0.78

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.83Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -16.4% over four weeks, 11.8% over 12 weeks, and 65.3% over one year. The current trend has remained active for 12 consecutive weeks.

Performance by holding period

1W8.6%
4W-16.4%
12W11.8%
26W21.1%
52W65.3%
Active trend streak12 weeks
Active weeks in one year43
Trend breadth82.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.44Latest activity-pressure read.
Pressure change-133.7%Four-week change in activity pressure.
Leadership12.86Latest relative-leadership reading.
RS change-60.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 76% Model confidence 73%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength66/100Blend of value, momentum, and quality. Underlying universe rank 35; rank 1 is best.
Value57/100Relative valuation strength. Underlying universe rank 44; rank 1 is best.
Quality56/100Profitability and accounting quality. Underlying universe rank 45; rank 1 is best.
Momentum57/100Medium-term price momentum. Underlying universe rank 44; rank 1 is best.
Growth57/100Revenue and earnings growth. Underlying universe rank 44; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
20.4x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
19.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
16.8%
Gross profit retained from each unit of revenue.
Operating margin
-83.2%
Operating profit retained from revenue.
Free-cash-flow margin
453.5%
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-13.7%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
1211.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-4.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

CORZ shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.38, expected move of 9.9%, and Sharemaestro trend signal active.

Conviction52/100
Expected move9.9%
Put/call volume0.38
Pressure51
Speculation43
Volatility95
Trend agreement46
Open options detail
Insider activity0 / 20

0 acquisitions and 20 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment47/100

Weighted news tone is neutral across 51 relevant articles.

11 positive · 26 neutral · 14 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings15dNext report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
Options expected move9.9%Nearest-chain priced movement where available.
52-week drawdown-25.3%Distance below the 52-week high.
13-week volatility9.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+12.9%Week of 10 Apr.
Worst week-21.2%Week of 3 Jul.
Latest week+8.6%Week of 24 Jul.

Shape of recent returns

Strong gains14
Modest gains0
Flat weeks0
Modest losses4
Sharp losses8
Recent vol9.2%13-week weekly-return volatility.
Base vol8.5%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew7.5% / -6.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape53/100

Trend, activity pressure, participation, and risk combine to a 53/100 tape read.

 Indicator analysis83/100

Latest 12-week confirmation: trend 12/12, activity pressure 11/12, relative leadership 12/12.

Activity pressure 0.83; 2 reversal markers Factors58/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 47; Small Cap Core rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options49/100

CORZ shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.38, expected move of 9.9%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 9.9% Sentiment47/100

Weighted news tone is neutral across 51 relevant articles.

Core Scientific (CORZ) Stock Looks Above Fair Value After A Big AI Deal Insiders0 / 20

0 acquisitions and 20 disposals in the latest 180-day insider tape.

 Earnings15d

Next report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202622.75 USD8.6%20.44 USD13.35 USD-0.4412.8645.9MOn
17 Jul 202620.94 USD-10.9%20.19 USD13.28 USD0.042.8239.6MOn
10 Jul 202623.49 USD9.6%20.01 USD13.22 USD0.5711.0052.3MOn
3 Jul 202621.43 USD-21.2%19.78 USD13.14 USD0.933.7660.7MOn
26 Jun 202627.20 USD-6.7%19.64 USD13.07 USD1.3132.6262.6MOn
19 Jun 202629.16 USD5.7%19.30 USD12.96 USD1.3736.5150.6MOn
12 Jun 202627.60 USD6.8%18.81 USD12.83 USD1.3834.1651.5MOn
5 Jun 202625.85 USD-3.7%18.39 USD12.71 USD1.4529.9272.1MOn
29 May 202626.85 USD6.3%18.20 USD12.61 USD1.5130.0766.0MOn
22 May 202625.26 USD4.3%18.03 USD12.49 USD1.4327.3055.6MOn
15 May 202624.21 USD5.6%17.83 USD12.38 USD1.4224.7168.1MOn
8 May 202622.92 USD12.6%17.66 USD12.29 USD1.2118.80121.7MOn
1 May 202620.35 USD-2.5%17.51 USD12.20 USD0.8212.3272.7MOff
24 Apr 202620.88 USD5.2%17.42 USD12.13 USD0.3818.0783.3MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.